Protecting Group-Free Synthesis of the Antimalaria Drug MMV693183
M4ALL has developed an efficient and highly regioselective synthesis of MMV693183 that involves only three
steps from readily available starting materials and provides the API in 46 % overall yield without requiring protecting groups.
Key Assumptions
- Shorten the number of steps required to make MMV693183 with a considerably higher overall yield.
- Eliminate the need for wasteful and expensive usage of protecting groups
Protecting Group-Free Synthesis of the Antimalaria Drug MMV693183